1. Health

Breast Reconstruction Market is driven by rising incidences of breast cancer

Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

Breast reconstruction is a procedure that restores the shape and look of the breast after a mastectomy or breast cancer surgery. Breast reconstruction can help restore the breasts appearance and regain woman's confidence. There are several different types of breast reconstruction procedures available including implant reconstruction (using implants), autologous reconstruction (using tissue from another part of the body like the abdomen, buttocks or back), and a combination of the two. Factors such as increasing incidence of breast cancer, rising awareness about breast reconstruction, favourable reimbursement policies are contributing to the growth of breast reconstruction market.

The Global Breast Reconstruction Market is estimated to be valued at US$ 2.1 Bn in 2024 and is expected to exhibit a CAGR of 7.0% over the forecast period 2024 to 2031.

Key Takeaways
Key players operating in the breast reconstruction market are Polytech Health & Aesthetics GmbH, Allergan, Mentor Worldwide LLC (Johnson & Johnson), Sientra Inc., GC Aesthetics, RTI Surgical, Inc., Groupe Sebbin SAS, Integra LifeSciences, and Wanhe. Key players are focusing on developing innovative breast reconstruction products and minimally invasive procedures to gain competitive edge.

The rising incidence of breast cancer is a key factor driving the growth of breast reconstruction market. According to WHO, globally over 2 million new breast cancer cases were diagnosed in 2020. The increasing breast cancer burden worldwide has augmented the demand for breast reconstruction procedures.

Technological advancements in breast reconstruction procedures such as 3D printing, ADM acellular dermal matrices are allowing plastic surgeons to determine the final shape and size of reconstructed breasts with better precision. 3D printing helps design patient-specific implants leading to superior aesthetic outcomes.

Market Trends
Increased Adoption of Acellular Dermal Matrix (ADM): Acellular dermal matrix is an innovative technology increasingly being used in breast reconstruction, especially for tissue expander-implant reconstruction. It provides better skin coverage and lower complication rates.
Growing Demand for Autologous Breast Reconstruction: With growing awareness, there is an increased preference for autologous breast reconstruction using abdominal tissue, buttocks tissue or back tissue as it provides a more natural aesthetic outcome as compared to implant reconstruction.

Market Opportunities
Emerging Economies: Emerging countries such as India, China, Brazil, Mexico offer high growth opportunities for players in breast reconstruction market owing to improving healthcare infrastructure, increasing medical tourism and rising disposable incomes.
3D Bioprinting: 3D bioprinting of patient-specific breast implants offers considerable opportunity. It provides customized solutions and can help reconstruct three-dimensional breast tissue accurately.